Herrera-Caceres J - Search Results

1

Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis.

Ajib K, Berjaoui MB, Herrera-Caceres J, Nason G, Tan GH, Tjong MC, Lajkosz K, Sridhar S, Fleshner NE, Zlotta AR, Catton C, Berlin A, Chung P, Kulkarni GS. Ajib K, et al. Among authors: herrera caceres j. Urol Oncol. 2021 Dec;39(12):835.e1-835.e7. doi: 10.1016/j.urolonc.2021.05.008. Epub 2021 Jun 13. Urol Oncol. 2021. PMID: 34134928

2

Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice.

Sanmamed N, Glicksman RM, Herrera-Caceres J, Lehrer EJ, Heaton J, Hansen AR, Chung P, Fleshner NE, Den RB, Zaorsky NG, Berlin A. Sanmamed N, et al. Urol Oncol. 2020 Nov;38(11):848.e1-848.e7. doi: 10.1016/j.urolonc.2020.04.019. Epub 2020 Jun 16. Urol Oncol. 2020. PMID: 32553790

3

Salvage radical prostatectomy following focal therapy: functional and oncological outcomes.

Herrera-Caceres JO, Nason GJ, Salgado-Sanmamed N, Goldberg H, Woon DTS, Chandrasekar T, Ajib K, Tan GH, Alhunaidi O, van der Kwast T, Finelli A, Zlotta AR, Hamilton RJ, Berlin A, Perlis N, Fleshner NE. Herrera-Caceres JO, et al. BJU Int. 2020 Apr;125(4):525-530. doi: 10.1111/bju.14976. Epub 2020 Jan 9. BJU Int. 2020. PMID: 31863617

4

Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.

Qaoud Y, Herrera-Caceres JO, Bass R, Berjaoui MB, Tiwari R, Kenk M, Lajkosz K, Finelli A, Perlis N, Klotz L, Fleshner N. Qaoud Y, et al. Among authors: herrera caceres jo. Urol Oncol. 2022 Jul;40(7):343.e1-343.e6. doi: 10.1016/j.urolonc.2022.03.019. Epub 2022 May 9. Urol Oncol. 2022. PMID: 35537905

5

Population-based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer.

Benidir T, Herrera-Caceres J, Wallis C, Lajkosz K, Fleshner N. Benidir T, et al. Among authors: herrera caceres j. Cancer Med. 2021 Apr;10(8):2636-2644. doi: 10.1002/cam4.3805. Epub 2021 Mar 12. Cancer Med. 2021. PMID: 33710797 Free PMC article.

6

Age Differences in Patient-reported Psychological and Physical Distress Symptoms in Bladder Cancer Patients - A Cross Sectional Study.

Ajaj R, Berlin A, Klaassen Z, Chandrasekar T, Wallis CJD, Ahmad AE, Herrera Cáceres JO, Leao R, Petrella AR, Fleshner N, Matthew A, Kulkarni GS, Goldberg H. Ajaj R, et al. Urology. 2019 Dec;134:154-162. doi: 10.1016/j.urology.2019.08.032. Epub 2019 Sep 2. Urology. 2019. PMID: 31487512

7

Required efficacy for novel therapies in BCG-unresponsive non-muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?

Wettstein MS, Naimark D, Hermanns T, Herrera-Caceres JO, Ahmad A, Jewett MAS, Kulkarni GS. Wettstein MS, et al. Cancer Med. 2020 May;9(10):3287-3296. doi: 10.1002/cam4.2980. Epub 2020 Mar 12. Cancer Med. 2020. PMID: 32163677 Free PMC article.

8

A High Percent Free Prostate Specific Antigen in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated with Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank Specimens.

Woon DTS, Herrera-Cáceres JO, Goldberg H, Shiakh H, Whelan E, Nason G, Ajib K, Tan GH, Chandrasekar T, Alhunaidi O, Finelli A, Zlotta A, Berlin A, Diamantis E, Fleshner N. Woon DTS, et al. J Urol. 2020 Aug;204(2):289-295. doi: 10.1097/JU.0000000000000808. Epub 2020 Feb 18. J Urol. 2020. PMID: 32068483

9

Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?

Herrera-Caceres JO, Gleave A, Lajkosz K, Goldberg H, Woon DTS, Berjaoui MB, Qaoud Y, Wettstein MS, Ahmad AE, Hamilton R, Kulkari G, Fleshner N. Herrera-Caceres JO, et al. Urol Oncol. 2021 Jul;39(7):431.e1-431.e8. doi: 10.1016/j.urolonc.2020.12.006. Epub 2021 Jan 23. Urol Oncol. 2021. PMID: 33495118

10

Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis.

Wettstein MS, David LA, Pazhepurackel C, Qureshi AA, Zisman A, Nesbitt M, Saba K, Herrera-Caceres JO, Fankhauser CD, Ahmad A, Hamilton RJ, Eberli D, Zlotta AR, Sulser T, Fleshner NE, Poyet C, Finelli A, Hermanns T, Kulkarni GS. Wettstein MS, et al. Prostate. 2021 Apr;81(5):286-294. doi: 10.1002/pros.24105. Epub 2021 Feb 18. Prostate. 2021. PMID: 33599318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page